The DOI matches its Crossref record; 1,073 of the 1,073 references it cites were found in a registry or an index.
Neurobiology of addiction
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 601–800 of 1,073
Distribution of galaninergic immunoreactivity in the brain of the mouse
Pérez, S. E., Wynick, D., Steiner, R. A., & Mufson, E. J. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1171 · Cited by 147
(1994) · PubMed · Cited by 146
Neuropeptide Y (NPY) and depression: From animal studies to the human condition
Redrobe, J. P., Dumont, Y., & Quirion, R. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02159-8 · Cited by 146
Gong, W., Neill, D. B., & Justice, J. B. (1996) · Brain Research · doi:10.1016/0006-8993(95)01222-2 · Cited by 146
Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder.
Mitchell, J. E., Specker, S. M., & de Zwaan, M. (1991) · PubMed · Cited by 145
Tønnesen, P., Tonstad, S., Hjalmarson, Å., Lebargy, F., van Spiegel, P. I., Hider, A., Sweet, R., & Townsend, J. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01185.x · Cited by 145
Ethanol consumption and serotonin‐1A (5‐HT1A) receptor function in heterozygous BDNF (+/–) mice
Hensler, J. G., Ladenheim, E. E., & Lyons, W. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01748.x · Cited by 144
Ling, W. W., SHOPTAW, S. J., & Majewska, D. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00128-0 · Cited by 144
Seizinger, B. R., Bovermann, K., Maysinger, D., Höllt, V., & Herz, A. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90200-9 · Cited by 144
Sexual behavior decreases pain sensitivity and stimulated endogenous opioids in male rats.
Szechtman, H., Hershkowitz, M., & Simantov, R. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90161-8 · Cited by 144
Vaidya, V. A., Terwilliger, R. Z., & Duman, R. S. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00006-3 · Cited by 144
Gilbert, J. G., Newman, A. H., Gardner, E. L., Ashby, C. R., Heidbreder, C. A., Pak, A. C., Peng, X., & Xi, Z. (2005) · Synapse · doi:10.1002/syn.20152 · Cited by 143
Shippenberg, T. S., & Rea, W. P. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00450-9 · Cited by 142
Dopamine-dependent responses to morphine depend on glucocorticoid receptors
Marinelli, M., Aouizerate, B., Barrot, M., Moal, M. L., & Piazza, P. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7742 · Cited by 142
Couwenbergh, C., van den Brink, W., Zwart, K., Vreugdenhil, C., van Wijngaarden-Cremers, P., & van der Gaag, R. J. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0535-6 · Cited by 141
Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system
Gustafson, E. L., Smith, K. E., Durkin, M. M., Walker, M. W., Gerald, C., Weinshank, R. L., & Branchek, T. A. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00017-x · Cited by 141
Sajdyk, T. J., Schober, D. A., & Gehlert, D. R. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00234-4 · Cited by 141
Pathological Gambling Among Youthful Multiple Substance Abusers in a Therapeutic Community
Lesieur, H. R., & Heineman, M. (1988) · British Journal of Addiction · doi:10.1111/j.1360-0443.1988.tb00509.x · Cited by 141
Schenk, S., Horger, B. A., Peltier, R., & Shelton, K. L. (1991) · Brain Research · doi:10.1016/0006-8993(91)90032-q · Cited by 141
Altered Serotonin 2A Receptor Activity in Women Who Have Recovered From Bulimia Nervosa
Kaye, W. H., Frank, G. K., Meltzer, C. C., Price, J. C., McConaha, C. W., Crossan, P. J., Klump, K. L., & Rhodes, L. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1152 · Cited by 140
Alvaro, J. D., Tatro, J. B., Quillan, J. M., Fogliano, M., Eisenhard, M. E., Lerner, M. R., Nestler, E. J., & Duman, R. S. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09317-4 · Cited by 140
Xi, Z., Gilbert, J. G., Pak, A. C., Ashby, C. R., Heidbreder, C. A., & Gardner, E. L. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04159.x · Cited by 140
Andreoli, M., Tessari, M., Pilla, M. A., Valerio, E., Hagan, J. J., & Heidbreder, C. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300183 · Cited by 140
Zardetto‐Smith, A. M., & Gray, T. S. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90183-z · Cited by 138
The evolving theory of basal forebrain functional—anatomical ‘macrosystems’
Zahm, D. S. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.06.003 · Cited by 138
A controlled family history study of bulimia
Hudson, J. I., Pope, H. G., Jonas, J. M., Yurgelun-Todd, D., & Frankenburg, F. R. (1987) · Psychological Medicine · doi:10.1017/s0033291700000684 · Cited by 137
Role of endogenous substance P in stress-induced activation of mesocortical dopamine neurones
Bannon, M. J., Elliott, P. J., Alpert, J. E., Goedert, M., Iversen, S. D., & Iversen, L. L. (1983) · Nature · doi:10.1038/306791a0 · Cited by 136
Gambling, substance use, and impulsivity during adolescence.
Vitaro, F., Ferland, F., Jacques, C. J., & Ladouceur, R. (1998) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.12.3.185 · Cited by 136
Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes.
Bartfai, T., Langel, Ü., Bedecs, K., Andell, S., Land, T., Gregersen, S., Åhrén, B., Girotti, P., Consolo, S., & Corwin, R. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11287 · Cited by 135
Jacobs, D. F., Marston, A. R., Singer, R. D., Widaman, K. F., Little, T., & Diaz‐Veizades, J. (1989) · Journal of Gambling Studies · doi:10.1007/bf01672427 · Cited by 135
Mantsch, J. R., Saphier, D., & Goeders, N. E. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37765-1 · Cited by 135
Anzengruber, D., Klump, K. L., Thornton, L. M., Brandt, H., Crawford, S. F., Fichter, M. M., Halmi, K. A., Johnson, C., Kaplan, A. S., LaVia, M., et al. (2006) · Eating Behaviors · doi:10.1016/j.eatbeh.2006.06.005 · Cited by 135
Karkowski, L. M., Prescott, C. A., & Kendler, K. S. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20001009)96:5<665::aid-ajmg13>3.0.co;2-o · Cited by 135
The dexamethasone suppression test and response to somatic treatment: a review.
Gitlin, M. J., & Gerner, R. H. (1986) · PubMed · Cited by 135
Salomon, L., Lanteri, C., Glowinski, J., & Tassin, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600839103 · Cited by 134
Hess, E. J., Albers, L. J., Le, H., & Creese, I. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24362-2 · Cited by 134
The GABA B receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat
Paterson, N. E., Froestl, W., & Markou, A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1637-1 · Cited by 133
Hwang, B. H., Zhang, J. K., Enters, C. L., Lumeng, L., & Li, T. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04220.x · Cited by 133
McBride, W. J., Murphy, J. M., Lumeng, L., & Li, T. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90137-2 · Cited by 133
de Graaf, R., Bijl, R., ten Have, M., Beekman, A., & Vollebergh, W. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.03.001 · Cited by 133
Blanc, G., Trovero, F., Vezina, P., Hervé, D., Godeheu, A. ‐., Glowinski, J., & Tassin, J. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00272.x · Cited by 133
Badia‐Elder, N. E., Stewart, R. B., Powrozek, T. A., Roy, K. F., Murphy, J. M., & Li, T. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02225.x · Cited by 133
Involvement of the Pallidal‐thalamocortical Circuit in Adaptive Behavior
Kalivas, P. W., Churchill, L., & ROMANIDES, A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09261.x · Cited by 133
Liljequist, S., & Engel, J. A. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(84)80033-7 · Cited by 133
Modulation of ethanol intake by serotonin uptake inhibitors.
Ca, N., Sellers, E. M., & Mo, L. (1986) · PubMed · Cited by 133
Laucht, M., Becker, K., Blomeyer, D., & Schmidt, M. H. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.025 · Cited by 132
Behavioral reactivity to stress
Khoshbouei, H., Cecchi, M., Dove, S., Javors, M. A., & Morilak, D. A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00683-9 · Cited by 132
Prevalence of anxiety disorder among alcoholics.
Weiss, K. J., & Rosenberg, D. J. (1985) · PubMed · Cited by 131
Coleman, E. (1987) · Journal of Chemical Dependency Treatment · doi:10.1300/j034v01n01_11 · Cited by 131
Mascia, M. S., Obinu, M. C., Ledent, C. A., Parmentier, M., Böhme, G. A., Impérato, A., & Fratta, W. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00656-1 · Cited by 131
Kask, A., Rägo, L., Mutulis, F., Pähkla, R., Wikberg, J. E. S., & Schiöth, H. B. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8389 · Cited by 130
MMPI characteristics of college freshman males who later became alcoholics.
Loper, R. G., Kammeier, M. L., & Hoffmann, H. (1973) · Journal of Abnormal Psychology · doi:10.1037/h0034959 · Cited by 130
An open naltrexone treatment study in pathological gambling disorder
Kim, S. W., & Grant, J. E. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200109000-00006 · Cited by 130
Pathological Gambling: A Clinical Guide to Treatment
Khantzian, E. J. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1992 · Cited by 130
Schank, J. R., Ventura, R., Puglisi‐Allegra, S., Alcaro, A., Cole, C. D., Liles, L. C., Seeman, P. M., & Weinshenker, D. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301000 · Cited by 129
Bell, S. M., Stewart, R. B., Thompson, S. C., & Meisch, R. A. (1997) · Psychopharmacology · doi:10.1007/s002130050258 · Cited by 129
Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial
Grant, J. E., Kim, S. W., Potenza, M. N., Blanco, C., Ibáñez, Á., Stevens, L., Hektner, J. M., & Zaninelli, R. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200307000-00007 · Cited by 127
Jaskiw, G. E., Karoum, F., Freed, W. J., Phillips, I., Kleinman, J. E., & Weinberger, D. R. (1990) · Brain Research · doi:10.1016/0006-8993(90)90138-2 · Cited by 127
The dopamine D1 receptor is a critical mediator for cocaine‐induced gene expression
Zhang, D., Zhang, L., Lou, D. W., Nakabeppu, Y., Zhang, J., & Xu, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01089.x · Cited by 126
Evaluation of an Anxiety-Related Phenotype in Galanin Overexpressing Transgenic Mice
Holmes, A., Yang, R. J., & Crawley, J. N. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:18:1-2:151 · Cited by 126
Role of Noradrenergic Signaling by the Nucleus Tractus Solitarius in Mediating Opiate Reward
Olson, V. G., Heusner, C. L., Bland, R. J., During, M. J., Weinshenker, D., & Palmiter, R. D. (2006) · Science · doi:10.1126/science.1119311 · Cited by 126
Thanos, P. K., Taintor, N. B., Rivera, S. N., Umegaki, H., Ikari, H., Roth, G., Ingram, D. K., Hitzemann, R., Fowler, J. S., Gatley, S. J., et al. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000125270.30501.08 · Cited by 125
Olmstead, M. C., Munn, E. M., Franklin, K. B. J., & Wise, R. A. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-13-05035.1998 · Cited by 125
Nelson, C. B., Heath, A. C., & Kessler, R. C. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.66.3.474 · Cited by 125
Personality Characteristics of Alcoholics as College Freshmen and at Time of Treatment
Kammeier, S. M. L., Hoffmann, H., & Loper, R. G. (1973) · Quarterly Journal of Studies on Alcohol · doi:10.15288/qjsa.1973.34.390 · Cited by 124
Numan, S., Lane-Ladd, S. B., Zhang, L., Lundgren, K. H., Russell, D., Seroogy, K. B., & Nestler, E. J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-24-10700.1998 · Cited by 124
Effect of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246 on neuropeptide Y release
King, P., Williams, G. H., Doods, H. N., & Widdowson, P. S. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00230-2 · Cited by 124
Drouin, C., Blanc, G., Villégier, A., Glowinski, J., & Tassin, J. (2001) · Synapse · doi:10.1002/syn.10023 · Cited by 124
Chen, G., & van den Pol, A. N. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-23-07711.1996 · Cited by 123
Ayhan, I. H., & Randrup, A. A. (1973) · Psychopharmacology · doi:10.1007/bf00429279 · Cited by 123
Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390
Creese, I., & Chen, A. W. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90549-7 · Cited by 123
Sex Determination in Malaria Parasites
Paul, R. E. L., Coulson, T. N., Raibaud, A., & Brey, P. T. (2000) · Science · doi:10.1126/science.287.5450.128 · Cited by 123
Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala
Sajdyk, T. J., Schober, D. A., Smiley, D. L., & Gehlert, D. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00679-7 · Cited by 123
Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength
Mackie, K. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803273 · Cited by 123
Ventura, R., Alcaro, A., & Puglisi‐Allegra, S. (2005) · Cerebral Cortex · doi:10.1093/cercor/bhi066 · Cited by 123
Epstein, L. H., & Leddy, J. J. (2005) · Appetite · doi:10.1016/j.appet.2005.04.006 · Cited by 123
Psychiatric Diagnoses in Adolescent Sex Offenders
Kavoussi, R. J., Kaplan, M. S., & BECKER, J. V. (1988) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198803000-00018 · Cited by 122
Galaverna, O., Seeley, R. J., Berridge, K. C., Grill, H. J., Epstein, A. N., & Schulkin, J. A. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90146-h · Cited by 122
GABA Antagonist and Benzodiazepine Partial Inverse Agonist Reduce Motivated Responding for Ethanol
Rassnick, S., D'amico, E., Riley, E. P., & Koob, G. F. (1993) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1993.tb00736.x · Cited by 122
Pathological Gambling Among Cocaine-Dependent Outpatients
Hall, G. W., Carriero, N. J., Takushi, R. Y., Montoya, I. D., Preston, K. L., & Gorelick, D. A. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1127 · Cited by 122
Dopamine Receptor Antagonists Fail to Prevent Induction of Cocaine Sensitization
White, F. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00093-6 · Cited by 122
Marino, M. J., Wittmann, M., Bradley, S. R., Hubert, G. W., Smith, Y., & Conn, P. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07001.2001 · Cited by 122
Hollander, E., Buchalter, A. J., & DeCaria, C. M. (2000) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70185-4 · Cited by 122
Witkin, H. A., Karp, S. A., & Goodenough, D. R. (1959) · Quarterly Journal of Studies on Alcohol · doi:10.15288/qjsa.1959.20.493 · Cited by 122
Samson, H. H., Tolliver, G. A., Pfeffer, A. O., Sadeghi, K. G., & Mills, F. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90357-1 · Cited by 121
Sauer, H., Fischer, W., Nikkhah, G., Wiegand, S. J., Brundin, P., Lindsay, R. M., & Björklund, A. (1993) · Brain Research · doi:10.1016/0006-8993(93)90560-a · Cited by 121
Wood, D., Ph, W., & Reimherr, F. W. (1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.1.95 · Cited by 120
Garcia, C., Chen, M. J., Garza, A. A., Cotman, C. W., & Russo‐Neustadt, A. A. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00192-1 · Cited by 120
Phosphorylation of DARPP-32 at Threonine-34 is Required for Cocaine Action
Zachariou, V., Sgambato, V., Sasaki, T. S., Svenningsson, P., Berton, O., Fienberg, A. A., Nairn, A. C., Greengard, P., & Nestler, E. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300832 · Cited by 120
(2004) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585626953 · Cited by 120
The relationship between eating disorders and substance use
Wolfe, W. L., & Maisto, S. A. (2000) · Clinical Psychology Review · doi:10.1016/s0272-7358(99)00009-4 · Cited by 119
Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons
Paladini, C. A., Fiorillo, C. D., Morikawa, H., & Williams, J. T. (2001) · Nature Neuroscience · doi:10.1038/85124 · Cited by 119
Alcoholism and Eating Disorders in Women of Fertile Age
Beary, M., Lacey, J. H., & Merry, J. (1986) · British Journal of Addiction · doi:10.1111/j.1360-0443.1986.tb00389.x · Cited by 119
Neuropeptide Y Produces Anxiety Via Y2-Type Receptors
Nakajima, M., Inui, A., Asakawa, A., Momose, K., Ueno, N., Teranishi, A., Baba, S., & Kasuga, M. (1998) · Peptides · doi:10.1016/s0196-9781(97)00298-2 · Cited by 119
Paterson, N. E., Froestl, W., & Markou, A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300524 · Cited by 119
Hatsukami, D. K., Owen, P., Pyle, R., & Mitchell, J. (1982) · Addictive Behaviors · doi:10.1016/0306-4603(82)90015-6 · Cited by 118
Liang, J., Chen, F., Krstew, E., Cowen, M. S., Carroll, F. Y., Crawford, D. J., Beart, P. M., & Lawrence, A. J. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.011 · Cited by 118
The dopamine D3 receptor plays an essential role in alcohol‐seeking and relapse
Vengeliene, V., Leonardi‐Essmann, F., Perreau‐Lenz, S., Gebicke‐Haerter, P. J., Drescher, K. U., Groß, G., & Spanagel, R. (2006) · The FASEB Journal · doi:10.1096/fj.06-6110com · Cited by 115
Fattore, L., Spano, M. S., Deiana, S., Melis, V., Cossu, G., Fadda, P., & Fratta, W. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.05.003 · Cited by 115
Anxiolytic-like action of centrally administered galanin
Bing, O., Møller, C. H., Engel, J. A., Söderpalm, B., & Heilig, M. A. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90846-d · Cited by 114
Enkephalinergic and GABAergic modulation of motor activity in the ventral pallidum.
Austin, M. C., & Kalivas, P. W. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20204-x · Cited by 113
Attention-Deficit/Hyperactivity Disorder in Males With Paraphilias and Paraphilia-Related Disorders
Kafka, M. P., & PRENTKY, R. A. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0709 · Cited by 113
Moss, H. B., Vanyukov, M. M., Yao, J. K., & Kirillova, G. P. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00216-9 · Cited by 113
Identifying Future Alcoholics with MMPI Alcoholism Scales
Hoffmann, H., Loper, R. G., & Kammeier, S. M. L. (1974) · Quarterly Journal of Studies on Alcohol · doi:10.15288/qjsa.1974.35.490 · Cited by 113
Brain Neuropeptide Υ (NPY) in Stress and Alcohol Dependence
Heilig, M. A., & Thorsell, A. (2002) · Reviews in the Neurosciences · doi:10.1515/revneuro.2002.13.1.85 · Cited by 113
Opioid Modulation of Ventral Pallidal Inputs
Napier, T. C., & Mitrovic, I. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09268.x · Cited by 112
Problem gamblers, problem substance users, and dual-problem individuals: an epidemiological study.
Feigelman, W. T., Wallisch, L., & Lesieur, H. R. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.3.467 · Cited by 112
Wang, X., Cen, X., & Lü, L. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01487-x · Cited by 111
Linnoila, M., Virkkunen, M., George, T., & Higley, D. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199309001-00008 · Cited by 110
Coccaro, E. F. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040062008 · Cited by 109
Emotional neurophysiology of the amygdala within the context of human cognition.
Halgren, E. (1992) · Cited by 108
Feenstra, M. G. P. (2000) · Progress in brain research · doi:10.1016/s0079-6123(00)26012-3 · Cited by 108
Gribkoff, V. K., Pieschl, R. L., Wisialowski, T. A., van den Pol, A. N., & Yocca, F. D. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-08-03014.1998 · Cited by 108
Koob, G. F., Bræstrup, C., & Britton, K. T. (1986) · Psychopharmacology · doi:10.1007/bf00181236 · Cited by 108
Maternal deprivation regulates serotonin 1A and 2A receptors in the infant rat
Vázquez, D. M., López, J. F., Hoers, H. V., Watson, S. J., & Levine, S. D. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02307-0 · Cited by 108
Hodge, C. W., & Cox, A. A. (1998) · Psychopharmacology · doi:10.1007/s002130050694 · Cited by 108
Gadd, C. A., Murtra, P., Felipe, C. D., & Hunt, S. P. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-23-08271.2003 · Cited by 107
Anxiolytic Action of a Neurokinin1 Receptor Antagonist in the Social Interaction Test
File, S. E. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)90002-2 · Cited by 107
Lifetime comorbidity of alcohol dependence in women with bulimia nervosa
Bulik, C. M., Sullivan, P. F., Carter, F. A., & Joyce, P. R. (1997) · Addictive Behaviors · doi:10.1016/s0306-4603(96)00053-6 · Cited by 107
GABAA receptor modulation of the rewarding and aversive effects of ethanol
Chester, J. A., & Cunningham, C. L. (2002) · Alcohol · doi:10.1016/s0741-8329(02)00199-4 · Cited by 107
Auclair, A. L., Cotecchia, S., Glowinski, J., & Tassin, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09150.2002 · Cited by 107
Butovsky, E., Juknat, A., Goncharov, I., Elbaz, J., Eilam, R., Zangen, A., & Vogel, Z. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03074.x · Cited by 106
Neuropeptide Y and glutamate block each other's phase shifts in the suprachiasmatic nucleus in vitro
Biello, S. M., Golombek, D. A., & Harrington, M. E. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00547-7 · Cited by 106
Laviolette, S. R., Nader, K., & van der Kooy, D. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00327-8 · Cited by 106
Lilenfeld, L., Kaye, W. H., Greeno, C. G., Merikangas, K. R., Plotnicov, K. H., Pollice, C., Rao, R., Strober, M. A., Bulik, C. M., & Nagy, L. M. (1997) · International Journal of Eating Disorders · doi:10.1002/(sici)1098-108x(199711)22:3<253::aid-eat4>3.0.co;2-m · Cited by 106
Hamzei, F., Dettmers, C., Rzanny, R., Liepert, J., Büchel, C., & Weiller, C. (2002) · NeuroImage · doi:10.1006/nimg.2002.1077 · Cited by 106
Reduced serotonin transporter binding in binge eating women
Kuikka, J. T., Tammela, L. I., Karhunen, L. J., Rissanen, A., Bergström, K., Naukkarinen, H., Vanninen, E. J., Karhu, J., Lappalainen, R. I., Repo‐Tiihonen, E., et al. (2001) · Psychopharmacology · doi:10.1007/s002130100716 · Cited by 105
Levitan, R. D., Masellis, M., Basile, V. S., Lam, R. W. M., Kaplan, A. S., Davis, C. A., Muglia, P., Mackenzie, B. E., Tharmalingam, S., Kennedy, S. H., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.013 · Cited by 105
Boyle, A. E. L., Segal, R., Smith, B. R., & Amit, Z. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90338-t · Cited by 105
Jokela, M. M., Keltikangas‐Järvinen, L., Mika Kivimaki, B., Puttonen, S., Elovainio, M. J., Rontu, R., & Lehtimäki, T. J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.356 · Cited by 105
O’Dell, L. E., & Parsons, L. H. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069278 · Cited by 105
RAPID COMMUNICATION: ALCOHOL-PREFERRING RATS HAVE FEWER DOPAMINE D2 RECEPTORS IN THE LIMBIC SYSTEM
Stefanini, E., FRAU, M., GARAU, M. G., GARAU, B., Fadda, F., & GESSA, G. L. (1992) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045210 · Cited by 105
Anandamide hydrolysis: a new target for anti-anxiety drugs?
Gaetani, S., Cuomo, V., & Piomelli, D. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.09.005 · Cited by 104
Crime, antisocial personality and pathological gambling
Blaszczynski, A. P., McConaghy, N., & Frankova, A. (1989) · Journal of Gambling Studies · doi:10.1007/bf01019760 · Cited by 104
Feeding can enhance dopamine turnover in the prefrontal cortex
Hernandez, L., & Hoebel, B. G. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90197-8 · Cited by 104
Ripley, T. L. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00295-2 · Cited by 104
Hiroi, N., & Graybiel, A. M. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961007)374:1<70::aid-cne5>3.0.co;2-k · Cited by 104
Eating disorders and cocaine abuse: a survey of 259 cocaine abusers.
Jonas, J. M., Gold, M. S., Sweeney, D. R., & Pottash, A. L. C. (1987) · PubMed · Cited by 104
Differential distribution of CREB in the mesolimbic dopamine reward pathway
Walters, C. L., Kuo, Y., & Blendy, J. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02090.x · Cited by 103
Long-term potentiation at excitatory amino acid synapses on midbrain dopamine neurons
Overton, P. G., Richards, C. D., Berry, M. S., & Clark, D. T. (1999) · Neuroreport · doi:10.1097/00001756-199902050-00004 · Cited by 103
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
Weinshenker, D., Miller, N. S., Blizinsky, K. D., Laughlin, M. L., & Palmiter, R. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212519999 · Cited by 103
Effects of Altered Amygdalar Neuropeptide Y Expression on Anxiety-Related Behaviors
Primeaux, S. D., Wilson, S. P., Cusick, M. C., York, D. A., & Wilson, M. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300705 · Cited by 103
Changes in reward‐induced brain activation in opiate addicts
Martin-Söelch, C., Chevalley, A. ‐., Künig, G., Missimer, J. H., Magyar‐Lehmann, S., Mino, A., Schultz, W., & Leenders, K. L. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01753.x · Cited by 103
Addictive behaviors and life problems before and after behavioral treatment of problem drinkers
Miller, W. R., Hedrick, K. E., & Taylor, C. A. (1983) · Addictive Behaviors · doi:10.1016/0306-4603(83)90041-2 · Cited by 103
Colombo, G. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.5.499 · Cited by 103
Subgroups among opiate addicts: A typological investigation.
Berzins, J. I., Ross, W. F., English, G. E., & Haley, J. V. (1974) · Journal of Abnormal Psychology · doi:10.1037/h0036237 · Cited by 102
Thanos, P. K., KATANA, J., ASHBYJR, C., Michaelides, M., Gardner, E., Heidbreder, C. A., & Volkow, N. D. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.03.013 · Cited by 102
Mulder, A. B., Arts, M. P. M., & Lopes, F. H. D. S. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01518.x · Cited by 101
Kask, A., Rägo, L., & Harro, J. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00076-6 · Cited by 101
Shi, T.-J., Tandrup, T., Bergman, E., Xu, Q., Ulfhake, B., & Hökfelt, T. G. M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00148-8 · Cited by 101
Ashby, C. R., Paul, M., Gardner, E. L., Heidbreder, C. A., & Hagan, J. J. (2003) · Synapse · doi:10.1002/syn.10188 · Cited by 101
Youth, Alcohol, and Social Policy
(1979) · Springer eBooks · doi:10.1007/978-1-4684-8538-7 · Cited by 100
Lü, L., Liu, D., & Ceng, X. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00840-8 · Cited by 100
Lability and Impulsivity Synergistically Increase Risk for Alcohol‐Related Problems
Simons, J. S., Carey, K. B., & Gaher, R. M. (2004) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-200032338 · Cited by 100
Berglind, W. J., Case, J. M., Parker, M. P., Fuchs, R. A., & See, R. E. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.08.064 · Cited by 100
BACLOFEN ANTAGONIZES INTRAVENOUS SELF-ADMINISTRATION OF NICOTINE IN MICE AND RATS
Fattore, L. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.5.495 · Cited by 100
Competing Theories of Marijuana Use: A Longitudinal Study
Ginsberg, I. J., & Greenley, J. R. (1978) · Journal of Health and Social Behavior · doi:10.2307/2136320 · Cited by 100
Ethanol-Associated Behaviors of Mice Lacking Norepinephrine
Weinshenker, D., Rust, N. C., Miller, N. S., & Palmiter, R. D. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03157.2000 · Cited by 99
Nowak, K., McBride, W. J., Lumeng, L., Li, T., & Murphy, J. M. (1998) · Psychopharmacology · doi:10.1007/s002130050695 · Cited by 99
Raymond, N. C., Grant, J. E., Kim, S. W., & Coleman, E. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200207000-00008 · Cited by 99
The GABAB Receptor Agonist Baclofen Attenuates Cocaine- and Heroin-Seeking Behavior by Rats
Ciano, P. D., & Everitt, B. J. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300088 · Cited by 99
Greenberg, D. M., Bradford, J., Curry, S., & O'Rourke, A. (1996) · PubMed · Cited by 99
Pallanti, S., Bernardi, S., Quercioli, L., DeCaria, C. M., & Hollander, E. (2006) · CNS Spectrums · doi:10.1017/s1092852900015145 · Cited by 98
Substance abuse vulnerability loci: converging genome scanning data
Uhl, G. R., Liu, Q., & Naiman, D. Q. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02719-1 · Cited by 98
Prazosin: Effect on psychomotor-stimulant cues and locomotor activity in mice
Snoddy, A. M., & Tessel, R. E. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90156-6 · Cited by 98
The Reinforcing Properties of Alcohol are Mediated by GABAA1 Receptors in the Ventral Pallidum
June, H. L., Foster, K. L., McKay, P. F., Seyoum, R., Woods, J. E., Harvey, S. C., Eiler, W. J. A., Grey, C., Carroll, M. R., McCane, S., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300239 · Cited by 97
Opioid mediation of cocaine-induced hyperactivity and reinforcement
Houdi, A. A., Bardo, M. T., & Loon, G. R. V. (1989) · Brain Research · doi:10.1016/0006-8993(89)90989-x · Cited by 97
Martin, C. S., Clifford, P. R., & Clapper, R. L. (1992) · Journal of Substance Abuse · doi:10.1016/0899-3289(92)90039-z · Cited by 97
Kask, A., Rägo, L., & Harro, J. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00838-2 · Cited by 97
Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking
Lang, U. E., Sander, T., Lohoff, F. W., Hellweg, R., Bajbouj, M., Winterer, G., & Gallinat, J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0647-1 · Cited by 97
Mantere, T., Tupala, E., Hall, H., Särkioja, T., Räsänen, P. K., Bergström, K., Callaway, J. C., & Tiihonen, J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.599 · Cited by 97
CNS mechanisms of alcohol self-administration.
McBride, W. J., Murphy, J. M., Gj, G., Ad, L., Yoshimoto, K., Lumeng, L., & Li, T. (1993) · PubMed · Cited by 97
Cognitive and Social Determinants of Food Intake
Nisbett, R. E., & Storms, M. D. (2017) · Routledge eBooks · doi:10.4324/9781315135656-19 · Cited by 97
Initiation into Adolescent Marijuana Use
Brook, J. S., Lukoff, I. F., & Whiteman, M. (1980) · The Journal of Genetic Psychology · doi:10.1080/00221325.1980.10532808 · Cited by 96
Dopamine D2 Receptor Availability is Associated with Subjective Responses to Alcohol
Yoder, K. K., Kareken, D. A., Seyoum, R., O’Connor, S., Wang, C., Zheng, Q., Mock, B. H., & Morris, E. D. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000171041.32716.42 · Cited by 96
Serotonin and substance P co-exist in dorsal raphe neurons of the human brain
Sergeyev, V., Hökfelt, T. G. M., & Hurd, Y. L. (1999) · Neuroreport · doi:10.1097/00001756-199912160-00044 · Cited by 96
Kirkham, T. C., & Cooper, S. J. (1988) · Physiology & Behavior · doi:10.1016/0031-9384(88)90386-1 · Cited by 96
Mandell, A. J., & Knapp, S. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780080083019 · Cited by 96
Chiara, G. D. (1997) · PubMed Central · Cited by 95
Hemmings, H. C., Williams, K. R., Konigsberg, W. H., & Greengard, P. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42625-1 · Cited by 95
Fletcher, P. J., Korth, K. M., & Chambers, J. W. (1999) · Psychopharmacology · doi:10.1007/s002130051170 · Cited by 95
Association analysis of the dopamine D4 gene exon III VNTR and heroin abuse in Chinese subjects
Li, T., Xu, K., Deng, H., Cai, G., Liu, J., Liu, X., Wang, R., Xiang, X., Zhao, J., Murray, R. M., et al. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000310 · Cited by 95
Neuropeptidergic regulation of feeding behavior
Sahu, A., & Kalra, S. P. (1993) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(93)90125-x · Cited by 94
Blockade of melanocortin transmission inhibits cocaine reward
Hsu, R., Taylor, J. R., Newton, S. S., Alvaro, J. D., Haile, C. N., Han, G. U., Hruby, V. J., Nestler, E. J., & Duman, R. S. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04038.x · Cited by 94
Noradrenergic role in the self-administration of morphine or amphetamine
Davis, W. M., Smith, S. G., & Khalsa, J. H. (1975) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(75)90059-3 · Cited by 94
Pharmacological evidence supporting a role for galanin in cognition and affect
Wrenn, C. C., & Crawley, J. N. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00156-1 · Cited by 94
Pak, A. C., Ashby, C. R., Heidbreder, C. A., Pilla, M. A., Gilbert, J. G., Xi, Z., & Gardner, E. L. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706006560 · Cited by 94
Guardia, J., Catafau, A. M., Batlle, F., Mart쬼, J. C., Segura, L., Gonzalvo, B., Prat, G., Carriñº®³, I., & Casas, M. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.127 · Cited by 94
Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa
STEIGER, H., YOUNG, S. N., NG YING KIN, N. M. K., KOERNER, N., ISRAEL, M., LAGEIX, P., & PARIS, J. (2001) · Psychological Medicine · doi:10.1017/s003329179900313x · Cited by 93
Serotonin Uptake Blockers and the Treatment of Alcoholism
Gorelick, D. A. (1989) · Recent developments in alcoholism · doi:10.1007/978-1-4899-1678-5_14 · Cited by 93
MMPI, clinical and research trends
Newmark, C. S. (1979) · Praeger eBooks · Cited by 93
Shi, T.-J., Cui, J.-G., Meyerson, B. A., Linderoth, B., & Hökfelt, T. G. M. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00105-0 · Cited by 93
Banks, K., & Gratton, A. P. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00306-6 · Cited by 93
Neuropeptide Y phase shifts the circadian clock in vitro via a Y2 receptor
Golombek, D. A., Biello, S. M., Rendon, R. A., & Harrington, M. E. (1996) · Neuroreport · doi:10.1097/00001756-199605170-00020 · Cited by 93
Regulation of CRE‐mediated transcription in mouse brain by amphetamine
Shaw‐Lutchman, T. Z., Impey, S., Storm, D. R., & Nestler, E. J. (2003) · Synapse · doi:10.1002/syn.10172 · Cited by 92
Treatment of Pathological Gambling with Carbamazepine
Haller, R., & Hinterhuber, H. (1994) · Pharmacopsychiatry · doi:10.1055/s-2007-1014292 · Cited by 92
Gerrits, M. A. F. M., Ramsey, N. F., Wolterink, G., & van Ree, J. M. (1994) · Psychopharmacology · doi:10.1007/bf02249340 · Cited by 92
Kafka, M. P., & Hennen, J. A. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0912 · Cited by 92
Atkins, J. B., Chlan‐Fourney, J., Nye, H. E., Hiroi, N., Carlezon, W. A., & Nestler, E. J. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199908)33:2<118::aid-syn2>3.0.co;2-l · Cited by 92
Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results
Hutchison, K. E., Monti, P. M., Rohsenow, D. J., Swift, R. M., Colby, S. M., Gnys, M., NIAURA, R. S., & Sirota, A. D. (1999) · Psychopharmacology · doi:10.1007/s002130050872 · Cited by 92
Research works printed but not linked: 81
- Mitchell, 1984, Bulimia in male patients, Psychosom, 25, 909, 10.1016/S0033-3182(84)72923-9 · doi:10.1016/s0033-3182(84)72923-9
- Robinson, 1986, Bulimia nervosa in the male: a report of nine cases, Psychol Med, 16, 795, 10.1017/S0033291700011818 · doi:10.1017/s0033291700011818
- Schneider, 1987, Bulimia in males: a matched comparison with females, Int J Eat Disord, 6, 235, 10.1002/1098-108X(198703)6:2<235::AID-EAT2260060207>3.0.CO;2-A · doi:10.1002/1098-108x(198703)6:2<235::aid-eat2260060207>3.0.co;2-a
- Mitchell, 1991, Comorbidity and medical complications of bulimia nervosa, J Clin Psychiatry, 52, 13
- Steinberg, 1990, Sexual addiction and compulsive gambling, Am J Prevent Psychiatry Neurol, 2, 39
- Welte, 2001, Alcohol and gambling pathology among US adults: prevalence, demographic patterns and comorbidity, J Stud Alcohol, 62, 706, 10.15288/jsa.2001.62.706 · DOI · Paper page
- Washton, 1989, Cocaine may trigger sexual compulsivity, US J Drug Alcohol Depend, 13, 8
- Lynch Wj, 2006, Psychiatric correlates of gambling in adolescents and young adults grouped by age at gambling onset, Arch Gen Psychiatry, 61, 1116, 10.1001/archpsyc.61.11.1116 · DOI · Paper page
- Chalkley, 1983, The clinical description of forty-eight cases of sexual fetishism, Br J Psychiatry, 142, 292, 10.1192/bjp.142.3.292 · doi:10.1192/bjp.142.3.292
- Hunter, 1992, The clinical utility of satiation therapy with juvenile offenders: variations and efficacy, Ann Sex Res, 5, 71, 10.1177/107906329200500201 · doi:10.1177/107906329200500201
- Slywka, 1993, Fluoxetine in alcoholism, Ann Pharmacother, 27, 1066
- Batki, 1991, Fluoxetine for cocaine abuse in methadone patients: preliminary findings, NIDA Res Monogr Ser, 105, 516
- Pollack, 1991, Fluoxetine treatment of cocaine abuse in heroin addicts, J Clin Psychiatry, 52, 31
- Edelstein, 1989, A clinical study of anti-depressant medications in the treatment of bulimia, Psychiatric Med, 7, 111
- Snaith, 1981, Collins SA: five exhibitionists and a method of treatment, Br J Psychiatry, 138, 126, 10.1192/bjp.138.2.126 · doi:10.1192/bjp.138.2.126
- Monti, 1996, Effect of naltrexone on urge to drink during alcohol cue exposure: preliminary results, Alcohol Clin Exp Res, 20, 92A
- Barbee, 2003, Topiramate in the Treatment of Severe Bulimia Nervosa with Comorbid Mood Disorders: A Case Series, Int J Eat Disord, 33, 468, 10.1002/eat.10154 · doi:10.1002/eat.10154
- Shiah, 2006, Topiramate for adolescent/young adult fetishism, Brown University Psychopharmacology Update, 17, 8
- Kranitz, 1972, Alcoholics, heroin addicts and nonaddicts. Comparisons on the MacAndrew Alcoholism Scale of the MMPI, Quart J Stud Alcohol, 33, 807, 10.15288/qjsa.1972.33.807 · doi:10.15288/qjsa.1972.33.807
- Burke, 1977, MacAndrew MMPI alcoholism scale: alcoholism and drug addictiveness, J Psychol, 96, 141, 10.1080/00223980.1977.9921428 · doi:10.1080/00223980.1977.9921428
- Arnon, 1974, Psychological differentiation in heroin addicts, Int J Addict, 9, 151, 10.3109/10826087409046777 · doi:10.3109/10826087409046777
- Karp, 1965, Psychological differentiation (field dependence) in obese women, Psychosom Med, 27, 238, 10.1097/00006842-196505000-00006 · doi:10.1097/00006842-196505000-00006
- Brown, 1975, Internal and external cues relating to fluid intake in obese and alcoholic persons, J Abnorm Psychol, 84, 660, 10.1037/0021-843X.84.6.660 · doi:10.1037/0021-843x.84.6.660
- Lansky, 1978, Blood alcohol level discrimination by alcoholics: the role of internal and external cues, J Consult Clin Psychol, 46, 953, 10.1037/0022-006X.46.5.953 · doi:10.1037/0022-006x.46.5.953
- Karp, 1965, Alcoholism and psychological differentiation: long-range effect of heavy drinking on field dependence, J Nerv Ment Dis, 140, 412, 10.1097/00005053-196506000-00003 · doi:10.1097/00005053-196506000-00003
- Vicary, 1983, Longitudinal perspectives on drug use: analyses from the New York longitudinal study, J Drug Ed, 13, 275, 10.2190/DM32-CRDA-2D8E-9QKU · doi:10.2190/dm32-crda-2d8e-9qku
- Sadava, 1973, Initiation to cannabis use: a longitudinal social psychological study of college freshmen, Can J Behav Sci, 5, 371, 10.1037/h0082360 · doi:10.1037/h0082360
- Gulas, 1976, On the question of pre-existing personality differences between users and nonusers of drugs, J Psychol, 92, 65, 10.1080/00223980.1976.9921335 · doi:10.1080/00223980.1976.9921335
- Sadava, 1977, Person-environment interaction and college student drug use: a multivariate longitudinal study, Genet Psychol Monogr, 96, 211
- Smith GM. Correlates of personality and drug use. I. RAUS cluster review no. 3. Rockville, MD: National Institute of Drug Abuse; 1977.
- Patton, 1998, Depression, anxiety, and smoking initiative: a prospective study over 3 years, Am J Public Health, 88, 1518, 10.2105/AJPH.88.10.1518 · DOI · Paper page
- Bulik, 1997, Eating disorders and antecedent anxiety disorders: a controlled study, Acta Psychiatr Scand, 96, 101, 10.1111/j.1600-0447.1997.tb09913.x · DOI · Paper page
- Avena, 2006, Sucrose sham feeding on a binge schedule releases accumbens dopamine repeatedly and eliminates the acetylcholine satiety response, Neuroscience, 139, 813, 10.1016/j.neuroscience.2005.12.037 · DOI · Paper page
- Dall’Olio, 1988, Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats, Psychopharmacology, 95, 381
- Volkow, 1999, Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels, Am J Psychiatry, 156, 1440, 10.1176/ajp.156.9.1440 · DOI · Paper page
- Comings, 1997, Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors, Mol Psychiatry, 2, 44, 10.1038/sj.mp.4000207 · DOI · Paper page
- Yan, 2004, Involvement of 5-HT1B receptors within the ventral tegmental area in regulation of mesolimbic dopaminergic neuronal activity via GABA mechanisms: a study with dual-probe microdialysis, Brain Res, 1021, 82, 10.1016/j.brainres.2004.06.053 · doi:10.1016/j.brainres.2004.06.053
- Le, 2005, Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats, Psychopharmacology (Berl), 179, 366, 10.1007/s00213-004-2036-y · DOI · Paper page
- Dickinson, 1988, Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by D-amphetamine and apomorphine in the rat. ATPsychopharmacology (Berl), 96, 521
- Estler, 1973, Effect of - and -adrenergic blocking agents and para-chlorophenylalanine on morphine- and caffeine-stimulated locomotor activity of mice, Psychopharmacologia, 28, 261, 10.1007/BF00429306 · doi:10.1007/bf00429306
- Weinshenker, 2002, Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals, Proc Natl Acad Sci USA, 99, 13873, 10.1073/pnas.212519999 · DOI
- Amit, 1976, Suppression of ethanol intake following administration of dopamine-beta-hydroxylase inhibitors in rats, Arch Int Pharmacodyn Ther, 223, 114
- Balfour, 2004, Sexual behavior and sex-associated environmental cues activate the mesolimbic system in male rats, Neuropsychopharmacology, 29, 718, 10.1038/sj.npp.1300350 · DOI · Paper page
- Chen, 2005, Role of GABAB receptors in GABA and baclofen-induced inhibition of adult rat cerebellar interpositus nucleus neurons in vitro, Brain Res Bull, 67, 10, 10.1016/j.brainresbull.2005.07.004 · doi:10.1016/j.brainresbull.2005.07.004
- Valles, 2005, The effects of the GABAA antagonist bicuculline on cocaine self-administration in rats exposed to lead during gestation/lactation, Pharmacology, Biochem Behav, 80, 611, 10.1016/j.pbb.2005.01.011 · doi:10.1016/j.pbb.2005.01.011
- Buczek, 1997, Opposite effects of Ro 15-4513 on acquisition and maintenance of ethanol drinking behavior in male Wistar rats, Alcohol Clin Exp Res, 21, 1667, 10.1111/j.1530-0277.1997.tb04505.x · doi:10.1111/j.1530-0277.1997.tb04505.x
- June, 1996, Effects of the benzodiazepine inverse agonist RO19-4603 alone and in combination with the benzodiazepine receptor antagonists flumazenil, ZK 93426 and CGS 8216, on ethanol intake in alcohol-preferring (P) rats, Brain Res, 734, 19, 10.1016/0006-8993(96)00276-4 · doi:10.1016/0006-8993(96)00276-4
- June, 1998, High-affinity benzodiazepine antagonists reduce responding maintained by ethanol presentation in ethanol-preferring rats, J Pharmacol Exp Ther, 284, 1006, 10.1016/S0022-3565(24)37309-4 · doi:10.1016/s0022-3565(24)37309-4
- Petry, 1995, Ro 15-4513 selectively attenuates ethanol, but not sucrose, reinforced responding in a concurrent access procedure; comparison to other drugs, Psychopharmacology (Berl), 121, 192, 10.1007/BF02245630 · doi:10.1007/bf02245630
- Di Ciano, 2003, The GABAB receptor agonist baclofen attenuates cocaine-and heroin-seeking behavior by rats, Neuropsychopharmacology, 28, 510, 10.1038/sj.npp.1300088 · DOI
- Ling, 1998, Baclofen as a cocaine anticraving medication: a preliminary clinical study, Neuropsychopharmacology, 18, 403
- Bartholini, 1985, GABA receptor agonists: pharmacological spectrum and therapeutic actions, Med Res Rev, 5, 55, 10.1002/med.2610050103 · doi:10.1002/med.2610050103
- Gong, 1998, GABAergic modulation of ventral pallidal dopamine release studied by in vivo microdialysis in the freely moving rat, Synapse, 29, 406, 10.1002/(SICI)1098-2396(199808)29:4<406::AID-SYN12>3.0.CO;2-O · doi:10.1002/(sici)1098-2396(199808)29:4<406::aid-syn12>3.0.co;2-o
- Iversen, 1994, Pharmacology. Endogenous cannabinoids, Nature, 372, 619, 10.1038/372619a0 · doi:10.1038/372619a0
- Cheer, 2007, Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation, J Neurosci, 27, 791, 10.1523/JNEUROSCI.4152-06.2007 · DOI · Paper page
- Berton, 2003, ΔFosB in the dorsal raphe mediates stress-induced transcriptional changes in substance P neurons, and modulates behavioral profiles in the learned helplessness model of depression, Abstr-Soc Neurosci, 29, 521
- Perrotti, 2003, Induction of ΔFosB in reward-related brain structures after chronic stress, Abstr-Soc Neurosci, 29
- Donohue, 2005, Effect of ethanol on DARPP-32 phosphorylation in transgenic mice that express human type VII adenylyl cyclase in brain, Alcohol: Clin Exp Res, 29, 310, 10.1097/01.ALC.0000156179.22112.0F · DOI
- Kasuya, 1998, Effects of an antisense oligodeoxynucleotide for neuropeptide Y mRNA on in vivo luteinizing hormone-releasing hormone release in ovariectomized female rhesus monkeys, Regul Pept, 75/76, 319, 10.1016/S0167-0115(98)00084-6 · doi:10.1016/s0167-0115(98)00084-6
- Schroeder, 2003, Neuropeptide-Y Y5 receptors modulate the onset and maintenance of operant ethanol self-administration, Alcohol Clin Exp Res, 27, 1912, 10.1097/01.ALC.0000098873.80433.BA · DOI
- Kiddle, 2003, Synthesis and binding affinity of neuropeptide Y at opiate receptors, Bioorg Med Chem Lett, 13, 1029, 10.1016/S0960-894X(03)00082-9 · doi:10.1016/s0960-894x(03)00082-9
- Bedecs, 1992, Galanin receptors and their second messengers in the lumbar dorsal spinal cord, Acta Physiol Scand, 144, 213, 10.1111/j.1748-1716.1992.tb09289.x · doi:10.1111/j.1748-1716.1992.tb09289.x
- Branchek, 2000, Galanin receptor subtypes, Trends Pharmacol Sci, 21, 109, 10.1016/S0165-6147(00)01446-2 · DOI · Paper page
- Minabe, 1996, The effect of the acute and chronic administration of CP-96345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study, Synapse, 22, 35, 10.1002/(SICI)1098-2396(199601)22:1<35::AID-SYN4>3.0.CO;2-J · doi:10.1002/(sici)1098-2396(199601)22:1<35::aid-syn4>3.0.co;2-j
- Kelley, 1989, Neurotensin, substance P, neurokinin-alpha, and enkephalin: injection into ventral tegmental area in the rat produces differential effects on operant responding, Psychopharmacology, 97, 243, 10.1007/BF00442258 · doi:10.1007/bf00442258
- Noailles And, 2002, Neurokinin receptors modulate the neurochemical actions of cocaine, Ann NY Acad Sci, 965, 267, 10.1111/j.1749-6632.2002.tb04168.x · doi:10.1111/j.1749-6632.2002.tb04168.x
- Gonzalez-Nicolini, 2002, NK-1 receptor blockade decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum, Brain Res, 931, 41, 10.1016/S0006-8993(02)02250-3 · doi:10.1016/s0006-8993(02)02250-3
- Fulton, 2000, Modulation of brain reward circuitry by leptin, Science, 287, 125, 10.1126/science.287.5450.125 · DOI · Paper page
- Piazza, 1998, The role of stress in drug self-administration, Trends Pharmacol Sci, 19, 67, 10.1016/S0165-6147(97)01115-2 · DOI · Paper page
- Soloman, 2006, Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons, Proc Nat Acad Sci USA, 103, 7476, 10.1073/pnas.0600839103 · DOI
- Salimov, 1996, Performance in the cross-maze and slip funnel tests of four pairs of rat lines selectively-bred for divergent alcohol drinking behavior, Addict Biol, 1, 273, 10.1080/1355621961000124886 · doi:10.1080/1355621961000124886
- Dong, 2004, CREB-mediated regulation of excitability and synaptic transmission in nucleus accumbens neurons, Soc Neurosci Abs, 577, 2
- Gerald, 1996, A receptor subtype involved in neuropeptide-Y-induced food intake, Nature (London), 382, 168, 10.1038/382168a0 · DOI · Paper page
- Holmes, 2006, A novel therapeutic target for depression, anxiety disorders drug addiction?, CNS Neurol Disord – Drug Targets, 5, 225, 10.2174/187152706776359600 · DOI
- Leibowitz, 2003, Ethanol intake increases galanin mRNA in the hypothalamus and withdrawal decreases it, Physiol Behav, 79, 103, 10.1016/S0031-9384(03)00110-0 · DOI
- Lewis, 2004, Galanin microinjection in the third ventricle increases voluntary ethanol intake, Alcohol Clin Exp Res, 28, 1822, 10.1097/01.ALC.0000148099.12344.C8 · DOI
- Thiele, 2004, Overlapping peptide control of alcohol self-administration and feeding, Alcohol Clin Exp Res, 28, 288, 10.1097/01.ALC.0000113777.87190.9C · DOI
- Moratalla, 1996, Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal, Neuron, 17, 147, 10.1016/S0896-6273(00)80288-3 · DOI · Paper page
- Koob, 1996, Neurobiological substrates for the anti-anxiety effects of ethanol, vol. 2, 477
- Piazza, 1991, Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine sensitization, Brain Res, 567, 169, 10.1016/0006-8993(91)91452-7 · DOI · Paper page
- Lusher, 2000, Dopamine D4 receptor gene and severity of dependence, Addict Biol, 5, 469, 10.1111/j.1369-1600.2000.tb00217.x · doi:10.1111/j.1369-1600.2000.tb00217.x
Cited by
Hypersexual disorder: A proposed diagnosis for DSM-V
Kafka, M. P. (2010) · Archives of Sexual Behavior · doi:10.1007/s10508-009-9574-7 · Cited by 1,095
Sleep disturbance as transdiagnostic: Consideration of neurobiological mechanisms
Harvey, A. G., Murray, G., Chandler, R. A., & Soehner, A. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.04.003 · Cited by 609
Steeves, T. D. L., Miyasaki, J., Zurowski, M., Lang, A. E., Pellecchia, G., Van Eimeren, T., Rusjan, P., Houle, S., & Strafella, A. P. (2009) · Brain · doi:10.1093/brain/awp054 · Cited by 502
A unified framework for addiction: Vulnerabilities in the decision process
Redish, A. D., Jensen, S., & Johnson, A. (2008) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0800472x · Cited by 501
Compulsive overeating as an addiction disorder. A review of theory and evidence
Davis, C., & Carter, J. C. (2009) · Appetite · doi:10.1016/j.appet.2009.05.018 · Cited by 480
Metadata
- Authors
- Goodman, A.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 75
- Issue
- 1
- Pages
- 266-322
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W142036609
- Cited by
- 413
- References
- 1,073
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.